SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-17-004668
Filing Date
2017-05-08
Accepted
2017-05-08 16:40:17
Documents
5
Period of Report
2017-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1701479_8k.htm 8-K 17893
2 EXHIBIT 99.1 t1701479_ex99-1.htm EX-99.1 327524
3 EXHIBIT 99.2 t1701479_ex99-2.htm EX-99.2 2883
4 GRAPHIC t1701479_ex99-1pg1.jpg GRAPHIC 13995
5 GRAPHIC t1701479_ex99-2pg1.jpg GRAPHIC 18628
  Complete submission text file 0001571049-17-004668.txt   394884
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 17823001
SIC: 2834 Pharmaceutical Preparations